Pharmacological Group
Latin name
Retigabinum ( Retigabini).
Used in the treatment of
- G40.2 Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
- G40.1 Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
- G40.0 Localization-related (focal)(partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset
- G40 Epilepsy
CAS Code
150812-12-7.
Pharmacological action
Противосудорожное, противоэпилептическое.
Analogs by action
- 40% Zonisamide
- 40% Brivaracetam
- 40% Lacosamide
- 33% Tiagabine
- Show all